Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
Arcutis Biotherapeutics, Inc.

Arcutis Biotherapeutics, Inc.

A clinical-stage biopharmaceutical company in California that focuses developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology.

Arcutis Biotherapeutics is a clinical-stage biopharmaceutical company in California that focuses developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology. Founded in 2016 in Westlake Village, California, United States by Bhaskar Chaudhuri, Arcutis Biotherapeutics is a company that focuses on treatments on the fields of inflammation and immunology. It discovers therapeutic molecules that act on validated physiologic targets to treat dermatological diseases and disorders. The company is made up of a team that has developed more than 50 FDA-approved products.

The company focuses on dermatological products that target diseases such as plaque psoriasis, atopic dermatitis, hand eczema, vitiligo, alopecia areata and seborrheic dermatitis. As of 2020, the company is currently developing four compounds: topical roflumilast cream (ARQ-151), topical roflumilast foam (ARQ-154), ARQ-252 and ARQ-255.

Timeline

October 2019
Arcutis Biotherapeutics, Inc. raises a $94,500,000 series C round from BlackRock, Goldman Sachs, HBM Healthcare Investments AG, Omega Funds and Vivo Capital.
2016
Arcutis Biotherapeutics, Inc. was founded by Bhaskar Chaudhuri.

Funding Rounds

Patents

Further Resources

Title
Author
Link
Type
Date

References

Golden logo
By using this site, you agree to our Terms & Conditions.